{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:39:43Z","timestamp":1785883183897,"version":"3.56.0"},"reference-count":50,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T00:00:00Z","timestamp":1084492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Wegener's granulomatosis (WG) is a rare disease characterized by granulomatous lesions, small vessel vasculitis and the presence of anti\u2010neutrophil cytoplasmic autoantibodies (C\u2010ANCAs) in the sera of affected patients. Their main target antigen is proteinase 3 (PR3), a neutrophil and monocyte\u2010derived neutral serine protease. Since the standard treatment of this severe autoimmune disease, with cyclophosphamide and corticosteroids, is associated with potential side\u2010effects, the development of a more specific immunotherapeutic agent is warranted. The key role of ANCA in the pathogenesis of vasculitis and the effectiveness of anti\u2010CD20 antibodies in patients with refractory WG points towards the importance of B cells in WG. We thus evaluated a new approach to selectively eliminate PR3\u2010specific autoreactive B cells by targeting the B\u2010cell receptor. For this purpose we used a bifunctional recombinant fusion protein consisting of the antigen PR3 and a toxin. The cytotoxic component of this novel fusion protein was the ribonuclease angiogenin, a human toxin with low immunogenicity. The toxin was stabilized by exchanging the catalytically relevant histidine in position 44 with glutamine to eliminate the autoproteolytic activity. PR3H44Q was fused either to the N terminus or to the C terminus of angiogenin. The recombinant proteins were expressed in 293T cells. Binding assays demonstrated the appropriate size and recognition by anti\u2010PR3 antibodies. Using TUNEL technology, we demonstrated that these autoantigen toxins kill proteinase 3\u2010specific B\u2010cell hybridomas selectively by inducing apoptosis. The data indicate that autoantigen\u2010toxins are promising tools in the treatment or co\u2010treatment of autoimmune diseases in which the antigen is known.<\/jats:p>","DOI":"10.1111\/j.1365-2567.2004.01875.x","type":"journal-article","created":{"date-parts":[[2004,5,14]],"date-time":"2004-05-14T12:58:42Z","timestamp":1084539522000},"page":"228-236","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Selective killing of B\u2010cell hybridomas targeting proteinase 3, Wegener's autoantigen"],"prefix":"10.1111","volume":"112","author":[{"given":"Katrin S.","family":"Reiners","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinrich P.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kr\u00fcssmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Csernok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang L.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke Pogge","family":"Von Strandmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,5,14]]},"reference":[{"key":"e_1_2_21_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108023450506"},{"key":"e_1_2_21_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-6-488"},{"key":"e_1_2_21_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.54.7.629"},{"key":"e_1_2_21_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310402"},{"key":"e_1_2_21_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380815"},{"key":"e_1_2_21_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91147-X"},{"key":"e_1_2_21_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.239"},{"key":"e_1_2_21_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.6.1888.1888"},{"key":"e_1_2_21_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114335"},{"key":"e_1_2_21_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.171.1.357"},{"key":"e_1_2_21_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.7.2487.419k07_2487_2496"},{"key":"e_1_2_21_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06518.x"},{"key":"e_1_2_21_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.11.4115"},{"key":"e_1_2_21_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1993.1015"},{"key":"e_1_2_21_16_2","first-page":"335","article-title":"Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells","volume":"141","author":"Savage CO","year":"1992","journal-title":"Am J Pathol"},{"key":"e_1_2_21_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80879-1"},{"key":"e_1_2_21_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119662"},{"key":"e_1_2_21_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(02)00273-9"},{"key":"e_1_2_21_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(03)00010-7"},{"key":"e_1_2_21_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215918"},{"key":"e_1_2_21_22_2","first-page":"S207\/473","article-title":"Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA\u2010associated glomerulonephritis","volume":"46","author":"Luqmani RA","year":"2002","journal-title":"Arthritis Rheum"},{"key":"e_1_2_21_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W"},{"key":"e_1_2_21_24_2","first-page":"27","article-title":"Immunotoxins against cancer","volume":"1198","author":"Brinkmann U","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"e_1_2_21_25_2","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V95.12.3909.012k04_3909_3914","article-title":"Ki\u20104 (scFv)\u2010ETA\u2032, a new recombinant anti\u2010CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice","volume":"95","author":"Barth S","year":"2000","journal-title":"Blood"},{"key":"e_1_2_21_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(99)00005-9"},{"key":"e_1_2_21_27_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008247110494"},{"key":"e_1_2_21_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.8.3165"},{"key":"e_1_2_21_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1380-2933(97)00070-5"},{"key":"e_1_2_21_30_2","first-page":"8737","article-title":"Human angiogenin fused to human CD30 ligand (Ang\u2010CD30L) exhibits specific cytotoxicity against CD30\u2010positive lymphoma","volume":"61","author":"Huhn M","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_21_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1046-5928(02)00709-X"},{"key":"e_1_2_21_32_2","first-page":"1113","article-title":"Ultrastructural localization of proteinase 3, the target antigen of anti\u2010cytoplasmic antibodies circulating in Wegener's granulomatosis","volume":"137","author":"Csernok E","year":"1990","journal-title":"Am J Pathol"},{"key":"e_1_2_21_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00089-9"},{"key":"e_1_2_21_34_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.149.4.1409"},{"key":"e_1_2_21_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.01079.x"},{"key":"e_1_2_21_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00475.x"},{"key":"e_1_2_21_37_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.152.9.4722"},{"key":"e_1_2_21_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01420.x"},{"key":"e_1_2_21_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90041-I"},{"key":"e_1_2_21_40_2","first-page":"399","article-title":"Phase I trial of a ligand fusion\u2010protein (DAB389IL\u20102) in lymphomas expressing the receptor for interleukin\u20102","volume":"91","author":"LeMaistre C","year":"1998","journal-title":"Blood"},{"key":"e_1_2_21_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.50.6.539"},{"key":"e_1_2_21_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.4.237"},{"key":"e_1_2_21_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb05434.x"},{"key":"e_1_2_21_44_2","first-page":"127","article-title":"ANCA and predicting relapse in systemic vasculitis","volume":"88","author":"Jayne DR","year":"1995","journal-title":"Qjm"},{"key":"e_1_2_21_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O"},{"key":"e_1_2_21_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92205-V"},{"key":"e_1_2_21_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-8235-4_10"},{"key":"e_1_2_21_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91761-A"},{"key":"e_1_2_21_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83199-3"},{"key":"e_1_2_21_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.11.1090"},{"key":"e_1_2_21_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxg076"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2567.2004.01875.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2567.2004.01875.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T01:27:18Z","timestamp":1697333238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2567.2004.01875.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,14]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1365-2567.2004.01875.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2567.2004.01875.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,14]]},"assertion":[{"value":"2004-05-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}